Selected research
Market Structure
Global Gene Mutagenesis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Gene Mutagenesis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Gene Mutagenesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gene Mutagenesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gene Mutagenesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Gene Mutagenesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gene Mutagenesis Service include Thermofisher, Azenta Life Sciences, Creative Biogene, Charles River, ACGT, Vectorbuilder, Creative Biolabs, Bio Basic and Applied Biological Materials, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Gene Mutagenesis Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gene Mutagenesis Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gene Mutagenesis Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gene Mutagenesis Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Gene Mutagenesis Service Segment by Company
Thermofisher
Azenta Life Sciences
Creative Biogene
Charles River
ACGT
Vectorbuilder
Creative Biolabs
Bio Basic
Applied Biological Materials
NovoPro Bioscience
Abace-Biology
Sangon Biotech
Genscript
Beijing Tsingke Biotech
Gene Mutagenesis Service Segment by Type
Site-Directed Mutagenesis
Random Mutagenesis
Gene Mutagenesis Service Segment by Application
Pharmaceutical Industry
Research
Others
Gene Mutagenesis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Mutagenesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Mutagenesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Mutagenesis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gene Mutagenesis Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Mutagenesis Service industry.
Chapter 3: Detailed analysis of Gene Mutagenesis Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Mutagenesis Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Site-Directed Mutagenesis
- Random Mutagenesis
Applications
- Pharmaceutical Industry
- Research
- Others
Companies covered
- Thermofisher
- Azenta Life Sciences
- Creative Biogene
- Charles River
- ACGT
- Vectorbuilder
- Creative Biolabs
- Bio Basic
- Applied Biological Materials
- NovoPro Bioscience
- Abace-Biology
- Sangon Biotech
- Genscript
- Beijing Tsingke Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Gene Mutagenesis Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Site-Directed Mutagenesis
- 1.2.3 Random Mutagenesis
- 1.3 Market Analysis by Application
- 1.3.1 Global Gene Mutagenesis Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Industry
- 1.3.3 Research
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Gene Mutagenesis Service Growth Trends by Region
- 1.5.1 Global Gene Mutagenesis Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Gene Mutagenesis Service Market Size by Region (2021-2026)
- 1.5.3 Gene Mutagenesis Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Gene Mutagenesis Service Market Dynamics
- 2.1 Gene Mutagenesis Service Industry Trends
- 2.2 Gene Mutagenesis Service Industry Drivers
- 2.3 Gene Mutagenesis Service Industry Opportunities and Challenges
- 2.4 Gene Mutagenesis Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Gene Mutagenesis Service Revenue by Company (2021-2026)
- 3.2 Global Gene Mutagenesis Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Gene Mutagenesis Service Key Company Head office and Area Served
- 3.4 Global Gene Mutagenesis Service Company, Product Type & Application
- 3.5 Global Gene Mutagenesis Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Gene Mutagenesis Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Gene Mutagenesis Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Gene Mutagenesis Service Tier 1, Tier 2, and Tier 3
4 Gene Mutagenesis Service Market by Type
- 4.1 Global Gene Mutagenesis Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Gene Mutagenesis Service Market Size by Type (2021-2032)
- 4.3 Global Gene Mutagenesis Service Market Size Share by Type (2021-2032)
5 Gene Mutagenesis Service Market by Application
- 5.1 Global Gene Mutagenesis Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Gene Mutagenesis Service Market Size by Application (2021-2032)
- 5.3 Global Gene Mutagenesis Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Thermofisher
- 6.1.1 Thermofisher Company Information
- 6.1.2 Thermofisher Business Overview
- 6.1.3 Thermofisher Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Thermofisher Gene Mutagenesis Service Product Portfolio
- 6.1.5 Thermofisher Recent Developments
- 6.2 Azenta Life Sciences
- 6.2.1 Azenta Life Sciences Company Information
- 6.2.2 Azenta Life Sciences Business Overview
- 6.2.3 Azenta Life Sciences Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Azenta Life Sciences Gene Mutagenesis Service Product Portfolio
- 6.2.5 Azenta Life Sciences Recent Developments
- 6.3 Creative Biogene
- 6.3.1 Creative Biogene Company Information
- 6.3.2 Creative Biogene Business Overview
- 6.3.3 Creative Biogene Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Creative Biogene Gene Mutagenesis Service Product Portfolio
- 6.3.5 Creative Biogene Recent Developments
- 6.4 Charles River
- 6.4.1 Charles River Company Information
- 6.4.2 Charles River Business Overview
- 6.4.3 Charles River Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Charles River Gene Mutagenesis Service Product Portfolio
- 6.4.5 Charles River Recent Developments
- 6.5 ACGT
- 6.5.1 ACGT Company Information
- 6.5.2 ACGT Business Overview
- 6.5.3 ACGT Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 ACGT Gene Mutagenesis Service Product Portfolio
- 6.5.5 ACGT Recent Developments
- 6.6 Vectorbuilder
- 6.6.1 Vectorbuilder Company Information
- 6.6.2 Vectorbuilder Business Overview
- 6.6.3 Vectorbuilder Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Vectorbuilder Gene Mutagenesis Service Product Portfolio
- 6.6.5 Vectorbuilder Recent Developments
- 6.7 Creative Biolabs
- 6.7.1 Creative Biolabs Company Information
- 6.7.2 Creative Biolabs Business Overview
- 6.7.3 Creative Biolabs Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Creative Biolabs Gene Mutagenesis Service Product Portfolio
- 6.7.5 Creative Biolabs Recent Developments
- 6.8 Bio Basic
- 6.8.1 Bio Basic Company Information
- 6.8.2 Bio Basic Business Overview
- 6.8.3 Bio Basic Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Bio Basic Gene Mutagenesis Service Product Portfolio
- 6.8.5 Bio Basic Recent Developments
- 6.9 Applied Biological Materials
- 6.9.1 Applied Biological Materials Company Information
- 6.9.2 Applied Biological Materials Business Overview
- 6.9.3 Applied Biological Materials Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Applied Biological Materials Gene Mutagenesis Service Product Portfolio
- 6.9.5 Applied Biological Materials Recent Developments
- 6.10 NovoPro Bioscience
- 6.10.1 NovoPro Bioscience Company Information
- 6.10.2 NovoPro Bioscience Business Overview
- 6.10.3 NovoPro Bioscience Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 NovoPro Bioscience Gene Mutagenesis Service Product Portfolio
- 6.10.5 NovoPro Bioscience Recent Developments
- 6.11 Abace-Biology
- 6.11.1 Abace-Biology Company Information
- 6.11.2 Abace-Biology Business Overview
- 6.11.3 Abace-Biology Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Abace-Biology Gene Mutagenesis Service Product Portfolio
- 6.11.5 Abace-Biology Recent Developments
- 6.12 Sangon Biotech
- 6.12.1 Sangon Biotech Company Information
- 6.12.2 Sangon Biotech Business Overview
- 6.12.3 Sangon Biotech Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Sangon Biotech Gene Mutagenesis Service Product Portfolio
- 6.12.5 Sangon Biotech Recent Developments
- 6.13 Genscript
- 6.13.1 Genscript Company Information
- 6.13.2 Genscript Business Overview
- 6.13.3 Genscript Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Genscript Gene Mutagenesis Service Product Portfolio
- 6.13.5 Genscript Recent Developments
- 6.14 Beijing Tsingke Biotech
- 6.14.1 Beijing Tsingke Biotech Company Information
- 6.14.2 Beijing Tsingke Biotech Business Overview
- 6.14.3 Beijing Tsingke Biotech Gene Mutagenesis Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Beijing Tsingke Biotech Gene Mutagenesis Service Product Portfolio
- 6.14.5 Beijing Tsingke Biotech Recent Developments
7 North America
- 7.1 North America Gene Mutagenesis Service Market Size (2021-2032)
- 7.2 North America Gene Mutagenesis Service Market Size by Type
- 7.2.1 North America Gene Mutagenesis Service Market Size by Type (2021-2026)
- 7.2.2 North America Gene Mutagenesis Service Market Size by Type (2027-2032)
- 7.2.3 North America Gene Mutagenesis Service Market Share by Type (2021-2032)
- 7.3 North America Gene Mutagenesis Service Market Size by Application
- 7.3.1 North America Gene Mutagenesis Service Market Size by Application (2021-2026)
- 7.3.2 North America Gene Mutagenesis Service Market Size by Application (2027-2032)
- 7.3.3 North America Gene Mutagenesis Service Market Share by Application (2021-2032)
- 7.4 North America Gene Mutagenesis Service Market Size by Country
- 7.4.1 North America Gene Mutagenesis Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Gene Mutagenesis Service Market Size by Country (2021-2026)
- 7.4.3 North America Gene Mutagenesis Service Market Size by Country (2027-2032)
- 7.4.4 North America Gene Mutagenesis Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Gene Mutagenesis Service Market Size (2021-2032)
- 8.2 Europe Gene Mutagenesis Service Market Size by Type
- 8.2.1 Europe Gene Mutagenesis Service Market Size by Type (2021-2026)
- 8.2.2 Europe Gene Mutagenesis Service Market Size by Type (2027-2032)
- 8.2.3 Europe Gene Mutagenesis Service Market Share by Type (2021-2032)
- 8.3 Europe Gene Mutagenesis Service Market Size by Application
- 8.3.1 Europe Gene Mutagenesis Service Market Size by Application (2021-2026)
- 8.3.2 Europe Gene Mutagenesis Service Market Size by Application (2027-2032)
- 8.3.3 Europe Gene Mutagenesis Service Market Share by Application (2021-2032)
- 8.4 Europe Gene Mutagenesis Service Market Size by Country
- 8.4.1 Europe Gene Mutagenesis Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Gene Mutagenesis Service Market Size by Country (2021-2026)
- 8.4.3 Europe Gene Mutagenesis Service Market Size by Country (2027-2032)
- 8.4.4 Europe Gene Mutagenesis Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Gene Mutagenesis Service Market Size (2021-2032)
- 9.2 China Gene Mutagenesis Service Market Size by Type
- 9.2.1 China Gene Mutagenesis Service Market Size by Type (2021-2026)
- 9.2.2 China Gene Mutagenesis Service Market Size by Type (2027-2032)
- 9.2.3 China Gene Mutagenesis Service Market Share by Type (2021-2032)
- 9.3 China Gene Mutagenesis Service Market Size by Application
- 9.3.1 China Gene Mutagenesis Service Market Size by Application (2021-2026)
- 9.3.2 China Gene Mutagenesis Service Market Size by Application (2027-2032)
- 9.3.3 China Gene Mutagenesis Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Gene Mutagenesis Service Market Size (2021-2032)
- 10.2 Asia Gene Mutagenesis Service Market Size by Type
- 10.2.1 Asia Gene Mutagenesis Service Market Size by Type (2021-2026)
- 10.2.2 Asia Gene Mutagenesis Service Market Size by Type (2027-2032)
- 10.2.3 Asia Gene Mutagenesis Service Market Share by Type (2021-2032)
- 10.3 Asia Gene Mutagenesis Service Market Size by Application
- 10.3.1 Asia Gene Mutagenesis Service Market Size by Application (2021-2026)
- 10.3.2 Asia Gene Mutagenesis Service Market Size by Application (2027-2032)
- 10.3.3 Asia Gene Mutagenesis Service Market Share by Application (2021-2032)
- 10.4 Asia Gene Mutagenesis Service Market Size by Country
- 10.4.1 Asia Gene Mutagenesis Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Gene Mutagenesis Service Market Size by Country (2021-2026)
- 10.4.3 Asia Gene Mutagenesis Service Market Size by Country (2027-2032)
- 10.4.4 Asia Gene Mutagenesis Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Gene Mutagenesis Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Gene Mutagenesis Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Gene Mutagenesis Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Gene Mutagenesis Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Gene Mutagenesis Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Gene Mutagenesis Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Gene Mutagenesis Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Gene Mutagenesis Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Gene Mutagenesis Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Gene Mutagenesis Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Gene Mutagenesis Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Gene Mutagenesis Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Gene Mutagenesis Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Gene Mutagenesis Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst